Universal Aging Signatures Revealed in Landmark Nature Study

BN-020 and SN-047 Contribute to a Major Advance in Aging Research

(Invent Biotechnologies Inc.)

Understanding why organisms age has been one of biology's most challenging questions. A recent study by Tyshkovskiy and colleagues, Universal Transcriptomic Hallmarks of Mammalian Ageing and Mortality (Nature, 2026), provides one of the most comprehensive answers to date by identifying common gene expression patterns associated with aging and mortality across multiple mammalian species and tissues.

Using large-scale single-nucleus transcriptomic analyses, the investigators examined how gene expression changes during aging in different organs and cell types. Despite the enormous diversity of tissues studied, the researchers discovered a surprisingly consistent set of molecular signatures that emerge with age. These findings suggest that aging is driven not only by tissue-specific processes but also by fundamental biological programs shared across mammals.

Major Findings

One of the study's most significant discoveries was the identification of universal transcriptomic hallmarks that consistently correlate with both biological aging and mortality risk. The researchers found that aging is accompanied by coordinated changes in gene networks involved in inflammation, cellular stress responses, immune regulation, metabolism, and tissue maintenance.

Importantly, these molecular signatures were observed across multiple organs and species, indicating that common mechanisms underlie aging throughout the mammalian body. The findings suggest that aging is characterized by a gradual shift toward stress-response and inflammatory programs, accompanied by declines in pathways associated with normal cellular function and tissue homeostasis.

The study also demonstrated that transcriptomic aging signatures are strongly associated with mortality, providing evidence that these molecular changes may serve as indicators of biological rather than simply chronological age. Such biomarkers could eventually contribute to improved assessment of aging interventions and age-related disease risk.

Collectively, the work provides a valuable framework for understanding how aging progresses at the molecular level and establishes a foundation for future efforts to develop therapies that target fundamental aging processes.

Role of BN-020 and SN-047

High-quality nuclei isolation was essential for generating the large single-nucleus datasets that made these discoveries possible. To support transcriptomic analysis across diverse tissue types, the investigators employed Invent Biotechnologies' spin column-based nuclear isolation technologies, including the BN-020 and the SN-047 Single Nucleus Isolation Kits.

BN-020 was used for neuronal tissues, while SN-047 provided a streamlined workflow for additional tissue types included in the study. Both kits enabled efficient recovery of intact nuclei suitable for high-quality sequencing and downstream bioinformatic analysis.

Why This Matters for Commercial Research Kits

The inclusion of BN-020 and SN-047 in a Nature publication represents a noteworthy milestone for commercial sample preparation technologies. Historically, many large-scale transcriptomic studies relied on customized laboratory protocols that were often difficult to reproduce across institutions.

In contrast, this study demonstrates that standardized commercial kits can generate data of sufficient quality to support discoveries published in one of the world's most prestigious scientific journals. The fact that data generated using BN-020 and SN-047 contributed to the identification of universal hallmarks of mammalian aging provides independent validation of the performance and reliability of Invent Biotechnologies' spin column-based nuclear isolation platform.

As single-nucleus sequencing continues to transform aging research, neuroscience, oncology, and precision medicine, robust and reproducible sample preparation methods will remain essential. The successful application of BN-020 and SN-047 in this landmark study highlights the growing importance of standardized technologies in enabling high-impact biological discoveries.

References

Tyshkovskiy, A., Kholdina, D., Davitadze, M., Molière, A., Moldakozhayev, A., Tongu, Y., ... & Gladyshev, V. N. (2026). Universal transcriptomic hallmarks of mammalian ageing and mortality. Nature, 1-16.